CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Gil Bar-Sela

OPENALEX: A5070627238↗ORCID: 0000-0001-6579-1841↗

Affiliations

Organizations

Emek Medical Centerauthorship · IL Rambam Health Care Campusauthorship · IL Rappaport Family Institute for Research in the Medical Sciencesauthorship · IL Technion – Israel Institute of Technologyauthorship · IL

Public evidence

4 connected articles

The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients.2022 · PubMed Central Open Access Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.2020 · Europe PMC Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients.2020 · Europe PMC The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care2013 · PubMed Central Open Access

Registered research

Connected studies

Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell Cancernct05969314

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Gil Bar-Sela - Medical Cannabis Research Engine